Jindal Drugs Private Limited, a active private limited company, was established on 04 November 1982 in Mumbai, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24114MH1982PTC028621. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹27.26 Cr and a paid-up capital of ₹11.96 Cr.
Formerly known as Jindal Dye Intermediate Limited, Jindal Dye Intermediate Private Limited. It upholds a compliant status. Employing 47 professional, Its leadership includes Mamta Ajay Jindal (Whole-Time Director), Ishaan Jindal (Director), Ajay Shrikrishan Jindal (Managing Director). Past directors included Sanjay Shrikrishan Jindal, Jayshree Vijay Jindal, Mamta Ajay Jindal. It holds ₹696.00 Cr open charges and ₹797.98 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 12A, Bakhtawar, 12Th Floor, 229 Nariman Point,, Mumbai, Maharashtra, 400021.
U24114MH1982PTC028621
028621
04 November 1982
₹27.26 Cr
₹11.96 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Jindal Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mamta Ajay Jindal | Whole-Time Director | 23 Mar 2015 | Current |
| Ishaan Jindal | Director | 08 Jul 2019 | Current |
| Ajay Shrikrishan Jindal | Managing Director | 01 Oct 2011 | Current |
| Shrikrishan Parameshwaridas Jindal | Whole-Time Director | 01 Oct 2011 | Current |
| Krishnabai Shrikrishan Jindal | Whole-Time Director | 23 Mar 2015 | Current |
| Aashna Ajay Jindal | Whole-Time Director | 24 Oct 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 23 Mar 2015 | Past |
| Pramod Abcsdd | Whole-Time Director | 04 Jan 2017 | Past |
| Pramod Abcsdd | Director | 01 Apr 2015 | Past |
| Pramod Abcsdd | Whole-Time Director | 04 Jan 2017 | Past |
| Pramod Abcsdd | Director | 01 Apr 2015 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jindal Drugs Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 5.11% increase. The company also saw a substantial fall in profitability, with a 31.85% decrease in profit. The company's net worth moved up by a moderate rise of 5.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Jindal Drugs had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,960,000,000.00
₹7,979,780,514.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2025 | Others | ₹30.00 Cr | Open |
| 31 Oct 2022 | Others | ₹50.00 Cr | Open |
| 25 Mar 2014 | Sbicap Trustee Company Limited | ₹600.00 Cr | Open |
| 19 Jul 1998 | Oversea- Chinese Banking Corp Ltd | ₹8.00 Cr | Open |
| 14 Jul 1998 | Oversea- Chinese Banking Corp Ltd | ₹8.00 Cr | Open |
Explore comprehensive loan charge details -
Jindal Drugs has a workforce of 47 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jindal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jindal Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 30.00 Cr registered on 09 May 2025 with Charge ID 101099714 was modified on 25 Nov 2025. was documented.
The activity Jindal Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101099714 was registered on 09 May 2025. was recorded as a recent event.
Progress on Jindal Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on A charge registered on 17 Jun 2020 via Charge ID 100344503 with Others was fully satisfied on 11 Jan 2023. was documented.
The activity A charge with Others amounted to Rs. 50.00 Cr with Charge ID 100653162 was registered on 31 Oct 2022. was completed.
The CIN of Jindal Drugs Private Limited is U24114MH1982PTC028621.
Jindal Drugs Private Limited is headquartered at 12A, Bakhtawar, 12Th Floor, 229 Nariman Point,, Mumbai, Maharashtra, 400021.
Jindal Drugs Private Limited was incorporated on 04 November 1982.
The current directors of Jindal Drugs Private Limited are
The primary industry of Jindal Drugs Private Limited is Manufacturing.
Jindal Drugs Private Limited is unlisted.
The authorized capital of Jindal Drugs Private Limited is ₹27.26 Cr, and the paid-up capital is ₹11.96 Cr.
The compliance status of Jindal Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX